## LVS: Las Vegas Sands Corp. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.91 indicates fundamental undervaluation. Quality metrics strong (ROE 66%). Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-5.8% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($63.18)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Las Vegas Sands Corp. stock outperforms market despite losses on the day**
- Source: MarketWatch | 20251203T165000 | Somewhat-Bearish | Relevance: 100%
- Las Vegas Sands Corp. (LVS) shares dropped 2.38% to $66.88 on Wednesday, marking its second consecutive day of losses. Despite this decline, the stock still outperformed the broader market, which saw the S&P 500 Index and Dow Jones Industrial Average rise by 0.30% and 0.86% respectively.

**2. Las Vegas Sands director Chafetz sells $2.09 million in stock**
- Source: Investing.com | 20251203T193500 | Neutral | Relevance: 100%
- Las Vegas Sands director Irwin Chafetz sold 30,000 shares of LVS common stock for $2.09 million on December 1, 2025. This transaction occurred after LVS shares surged 63% over six months, trading near its 52-week high with a market capitalization of $45.3 billion. Analysts from Goldman Sachs, Stifel, Mizuho, CFRA, and Wells Fargo have issued positive reports and increased price targets for LVS, citing strong performance, particularly from its Singapore operations.

**3. One Fortune 500 Company is Making a Big Bet on the Future of Texas Gambling**
- Source: www.sharewise.com | 20251203T033716 | Neutral | Relevance: 100%
- Las Vegas Sands Corporation, a Fortune 500 company, is significantly increasing its investment and presence in Texas despite the state's current legal restrictions on gambling. This aggressive strategy includes real estate purchases near Dallas and the acquisition of a majority stake in the NBA's Dallas Mavericks, with plans for a new arena and casino complex. While Texas casino legalization faces an uphill battle and recent political setbacks, Las Vegas Sands appears committed to a long-term strategy, betting on eventual legislative change.

**4. Las Vegas Sands (NYSE:LVS) Given New $75.00 Price Target at Seaport Global Securities**
- Source: MarketBeat | 20251202T150650 | Somewhat-Bullish | Relevance: 100%
- Seaport Global Securities has raised its price target for Las Vegas Sands (NYSE:LVS) to $75.00 from $66.00, maintaining a "buy" rating after the casino operator reported strong quarterly earnings. Despite the positive analyst outlook and earnings beat, the article highlights significant insider selling activity totaling approximately $130 million in the past 90 days. The stock's performance and recent insider and institutional investor activities are also detailed.

**5. Las Vegas Sands (NYSE:LVS) Price Target Raised to $80.00**
- Source: MarketBeat | 20251202T135331 | Bullish | Relevance: 100%
- Argus raised its price target for Las Vegas Sands (NYSE:LVS) to $80.00 from $65.00, maintaining a "buy" rating, indicating a potential 17.4% upside. This follows the company's strong third-quarter earnings beat, with EPS of $0.78 and revenue of $3.33 billion. Despite the positive analyst outlook, significant insider selling has occurred, with executives disposing of a substantial number of shares.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | Argus Research | $80 | $65 | +23% |
| 2025-11-18 | Wells Fargo | $66 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | Argus Research | main | Buy |
| 2025-11-18 | Wells Fargo | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($68.68M) |
| Sells | 12 ($14.30M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 6.2% (-2.0%)
- Capital Research Glo: 5.0% (-30.9%)
- Blackrock Inc.: 4.0% (-0.1%)
- Price (T.Rowe) Assoc: 2.2% (-7.8%)
- State Street Corpora: 2.1% (-7.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.8% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $14M sold (12 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.91 indicates undervaluation relative to growth. Forward P/E 21.0x stretched relative to 10% growth. Quality metrics strong (ROE 66%). Analyst sentiment positive (1 raises, avg +23%). Insider buying signal ($68.7M), management confidence. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $45.4B |
| Beta | 0.97 |
| 52W Range | $30.18 - $70.45 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.91 |
| Forward P/E | 21.0 |
| Current P/E | 23.0 |
| YoY Growth | 9.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 5.5% to -0.3% (-5.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.3pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.35% (CS: 49) | Neutral |
| RSI_14 | 61.6 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 1.015x | Above |
| vs SMA50 | 1.141x | Above |
| vs SMA200 | 1.380x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $66.88
- **Stop Loss:** $63.18 (5.5% risk)
- **Target:** $74.28 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 308
- **Position Value:** $20,599.04
- **Portfolio %:** 20.60%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-28 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.78 | +25.4% |
| 2025Q2 | $0.53 | $0.79 | +48.9% |
| 2025Q1 | $0.57 | $0.59 | +3.8% |
| 2024Q4 | $0.58 | $0.54 | -6.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*